Polymeric nano-in-microparticles for pulmonary delivery of remdesivir against SARS-CoV-2

20260 citationsJournal Articlediamond Open Access

Authors

We developed an inhalable formulation of polycaprolactone/DPPC/lactose nano-in-microparticles (RDV-PCL-MP) for the pulmonary delivery of remdesivir.

Good health and well-being

Published in: RSC Pharmaceutics

Volume 3, Issue 2, pp. 552-563

Field-Weighted Citation Impact: 0.00